美国国防部推出军人睾酮检测指南


2026年9月2日 / 美国东部时间晚上7:40 / 哥伦比亚广播公司新闻

美国国防部周三宣布,将开始要求30岁及以上的男性军人接受睾酮缺乏症筛查,这一举措是在国防部长皮特·赫格斯瑟夏季提出该要求后出台的。

美国国防卫生局发布了一套相关临床检测指南,检测将在军人的常规健康评估期间进行。

指南要求对30岁及以上的现役军人和预备役军人进行筛查和血液检测。被诊断为性腺功能减退症(即睾酮水平低下)的军人将接受后续筛查和治疗,必要时可接受睾酮替代疗法。

赫格斯瑟在7月份表示,如果为军人推荐治疗方案,“是否接受睾酮替代疗法完全由你自己决定”。

30岁以下的男性军人可自愿选择每年接受筛查。

指南还要求询问女性军人是否出现激素调节异常的相关症状,必要时将其转介进行进一步评估。

美国国防部在一份声明中表示,其目标是“投资于作战人员的健康,提升他们的作战效能,并最大限度地提高部队战备水平”。

此次推广检测计划距赫格斯瑟在社交媒体上发布题为“战争的高科技部门”的视频、宣布军方将推行强制性睾酮筛查仅两个半月。

这位国防部长表示:“这项举措并非关于人工增强,而是在于恢复和优化您的自然生理能力,保护您的健康寿命,并确保您拥有维持作战所需的生理基础。”

周三发布的健康指南将睾酮水平称为“衡量作战人员战备状态的关键生物标志物,直接影响体力、骨密度、有氧耐力、抑郁症状和心血管健康”。

指南同时警告,军人的睾酮水平下降风险可能尤其高。

医学专家此前也曾指出这一风险。马迪根陆军医疗中心的泌尿科医生西奥多·克里斯托莫-怀恩陆军少校去年在美国食品药品监督管理局的一个专家小组会议上表示:“这些军人经历的高作战节奏和高压环境实际上会降低睾酮水平,有时是急性下降,有时甚至会造成长期影响。”

一些研究表明,承担高压力任务的军人——包括特种部队成员——面临激素异常和其他健康问题的风险尤其高,研究人员将这种情况称为“操作员综合征”。

克里斯托莫-怀恩去年表示,这种现象可能与部分军人面临的“慢性压力、爆炸冲击、创伤性脑损伤和睡眠障碍”有关。

https://www.cbsnews.com/video/testosterone-replacement-therapy-surges-in-popularity-among-men-and-women/

睾酮替代疗法在男性和女性中越来越受欢迎

(04:10)

Pentagon rolls out guidelines to test service members for testosterone

September 2, 2026 / 7:40 PM EDT / CBS News

The Pentagon will begin requiring male service members ages 30 and older to get screened for testosterone deficiency, the military announced Wednesday, after Defense Secretary Pete Hegseth called for the change over the summer.

The Defense Health Agency released a set of clinical guidelines for the tests, which will take place during service members’ regular health assessments.

It calls for screenings and blood tests for active-duty troops and reservists ages 30 and over. Service members who are diagnosed with hypogonadism, or low testosterone, will get follow-up screenings and treatment, including testosterone replacement therapy, if needed.

Hegseth said in July that if treatment is recommended for service members, “it’s entirely your choice to receive testosterone replacement therapy.”

Male service members under the age of 30 will be offered optional annual screenings.

The guidelines call for female service members to be asked if they have any symptoms of hormonal dysregulation and referred for further assessment if needed.

In a statement, the Defense Department said its goal is to “invest in the health of its warfighters, strengthen their performance, and maximize force readiness.”

The testing push comes two and a half months after Hegseth announced the military would be introducing mandatory testosterone screening in a social media video titled “The High-T Department of War.”

“This initiative, it’s not about artificial enhancement. It’s about restoring and optimizing your natural capabilities, protecting your longevity and ensuring you have the biological foundation required to sustain the fight,” the defense secretary said.

The health guidance issued Wednesday calls testosterone levels a “critical biological marker for Warfighter readiness, directly impacting physical strength, bone density, aerobic fitness, depressive symptoms, and cardiovascular health.”

It also warns that service members may be particularly at risk of decreased testosterone.

Medical experts have pointed to that risk in the past. Army Major Theodore Criostomo-Wynne, a Madigan Army Center urologist, said during a Food and Drug Administration panel last year that “the high operations tempo and high stress that these service members go through can actually decrease testosterone, sometimes acutely and sometimes even in the long term.”

Some studies indicate that service members in high-stress roles — including members of the Special Operations Forces — face an especially high risk of hormone issues and other medical conditions, a condition researchers have called “Operator Syndrome.”

Crisostomo-Wynne said last year the phenomenon may be linked to the “chronic stress, blast exposure, traumatic brain injuries and sleep disruptions” that some service members face.

https://www.cbsnews.com/video/testosterone-replacement-therapy-surges-in-popularity-among-men-and-women/

Testosterone replacement therapy surges in popularity among men and women

(04:10)

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

湘ICP备2026001899号-2